Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chronic Condition OTCs Safety Questioned By Consumers - CHPA Survey

This article was originally published in The Tan Sheet

Executive Summary

U.S. consumers express ambivalence when it comes to treating chronic conditions with OTC medications, according to a survey released by the Consumer Healthcare Products Association March 21.
Advertisement

Related Content

Supplement Safety, Content Oversight Deemed Inadequate By 60% In Surveys
Supplement Safety, Content Oversight Deemed Inadequate By 60% In Surveys
Supplement Safety, Content Oversight Deemed Inadequate By 60% In Surveys
Antihistamine OTC Switch Petition Slated For NDAC Debate May 11
Antihistamine OTC Switch Petition Slated For NDAC Debate May 11

Topics

Advertisement
UsernamePublicRestriction

Register

PS092331

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel